港股異動丨美圖大升超10%,獲創始人吳澤源增持
美圖(1357.HK)盤中一度升10.48%至2.74港元。消息面上,公司公佈,6月18日,創始人、董事長及首席執行官吳澤源於公開市場購買100萬股公司股份,每股平均價2.48港元。增持後,吳澤源共計持有5.75億股,佔公司股本12.69%,且不排除會於適當時候進一步增持。另外還值得注意的是,美圖於6月12日舉辦美圖影像節,併發布6款產品,包括專業級AI批量修圖軟件美圖雲修V2、AI口播視頻工具開拍V2、AI設計工具美圖設計室V3、設計服務平台站酷設計服務、遊戲廣吿AI製作與投放平台奇覓、AI短片創作工具MOKI。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.